ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "prevention"

  • Abstract Number: 1856 • ACR Convergence 2023

    Improving Recombinant Zoster Vaccination Rates in Patients Receiving Immunosuppressive Therapy in the Rheumatology Clinic at the Orlando VA Healthcare System – a Quality Improvement Project

    Kathlyn Camargo Macias1, Ravi Shahu Khal1, Ariail Schmitz2, Kathleen McCabe1, Taylor Kann1, Marilyn Mosquera3 and Ashwini Komarla4, 1University of Central Florida, Orlando, FL, 2University of Central Florida, St. Cloud, FL, 3University of Central Florida, Casselberry, FL, 4ORLANDO VAMC, Orlando, FL

    Background/Purpose: Herpes zoster is a painful rash that involves one to three adjacent dermatomes, secondary to reactivation of latent varicella-zoster virus (VZV). About 95 %…
  • Abstract Number: 0616 • ACR Convergence 2023

    Does Systemic Sclerosis Affect the Interpretation of Mammograms? A Retrospective Cohort Study

    Lea Meir1, Tegveer Sandhu2, Weiwei Chi2 and Gabriela Santiago2, 1Icahn School of Medicine, New York, NY, 2Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: Systemic Sclerosis is an autoimmune disorder marked by thickened and hardened skin. Cutaneous cutis, the deposition of insoluble calcium salts in the skin and…
  • Abstract Number: 1895 • ACR Convergence 2023

    Comparative Analysis of Existing Tools in Assessing Cardiovascular Risk in Patients with Rheumatoid Arthritis: Exploring the Inadequacies

    Pritee Shrestha1, Peter Larsen1 and Pablo Weilg Espejo2, 1Mercy One North Iowa Medical Center, Mason City, IA, 2Boston Medical Center, Chelsea, MA

    Background/Purpose: Patients with Rheumatoid Arthritis (RA) are at increased risk of cardiovascular disease (CVD). Despite multiple CVD risk tools available, reliability to RA population is…
  • Abstract Number: 055 • 2023 Pediatric Rheumatology Symposium

    COVID-19 Vaccination in Children with Rheumatic Diseases: Results of a CARRA-wide Survey

    Beth Rutstein1, Merav Heshin Bekenstein2, Maria Schletzbaum3, Nora Singer4, Rebecca Sadun5, Melanie Kohlheim6, Vincent Del Gaizo7, Kelly Wise8, Melica Nikahd9, Guy Brock9, Monica Ardura8, Vidya Sivaraman10 and For the CARRA Investigators11, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2Tel Aviv Medical Center, Tel Aviv, Israel, 3Medical College of Wisconsin, Milwaukee, WI, 4Metro Health, Cleveland, OH, 5Duke University, Durham, NC, 6None, Columbus, OH, 7CARRA, Washington, DC, 8Nationwide Children's Hospital, Columbus, OH, 9The Ohio State University, Columbus, OH, 10Nationwide Children's Hospital/ The Ohio State University, Columbus, OH, 11Duke University Medical Center, Durham, NC

    Background/Purpose: Children receiving immunosuppressive therapies (IST) have a higher risk of hospitalization from COVID-19. COVID-19 vaccines significantly reduce the likelihood of severe disease or death.…
  • Abstract Number: L08 • ACR Convergence 2022

    Breakthrough Acute COVID-19 Infection During the US Omicron Surge Following Administration of Tixagevimab/Cilgavimab in Immunocompromised Patients with Rheumatologic Disorders

    Christopher Podgorski1 and Deborah Parks2, 1BJC/Washington University Consortium, St. Louis, MO, 2Washington University/B-JH/SLCH Consortium, St. Louis, MO

    Background/Purpose: Treatment with Tixagevimab/Cilgavimab 150/150 mg was authorized by the FDA on 12/8/21 under an Emergency Use Authorization as pre-exposure prophylaxis against COVID-19 infection. The…
  • Abstract Number: L16 • ACR Convergence 2022

    Innovative Anti-pneumococcal Vaccine Strategies versus Standard Vaccination Regimen in Patients with ANCA-associated Vasculitides Receiving Rituximab Therapy: A Multicenter Randomized Controlled Trial (PNEUMOVAS)

    Benjamin Terrier1, Laura Richert2, Grégory Pugnet3, Olivier Aumaitre4, Olivier Moranne5, Elisabeth Diot6, Alexandre Karras7, Fabrice Bonnet8, Claire De Moreuil9, Eric Hachulla10, Thomas Le Gallou11, Céline Lebas10, Francois Maurier12, Cédric Rafat7, Maxime Samson13, Jean-Francois Augusto14, Grégoire Couvrat-Devergne15, Cécile Janssen16, Thierry Martin17, Thomas Quemeneur18, Pierre-Louis Caron19, Cécile-Audrey Durel20, Khalil El Karoui7, Aurélie Grados21, Mathieu Puyade22, Virginie Rieu4, Yurdagul Uzunhan23, Jean-Francois Viallard8, Xavier Puéchal7, Loic Guillevin7, Noémie Huchet8, Hendy Abdoul7, Carine Bellera8, Frédéric Batteux7 and Odile Launay7, 1Cochin Hospital, Paris, France, 2EUCLID, Bordeaux, France, 3CHU, Toulouse, France, 4CHU, Clermont-Ferrand, France, 5CHU, Nimes, France, 6CHU, Tours, France, 7CHU, Paris, France, 8CHU, Bordeaux, France, 9CHU, Brest, France, 10CHU, Lille, France, 11CHU, Rennes, France, 12CH, Metz, France, 13CHU, Dijon, France, 14CHU, Angers, France, 15CH, La Roche sur Yon, France, 16CH, Annecy, France, 17CHU, Strasbourg, France, 18CH, Valenciennes, France, 19CHU, Grenoble, France, 20CHU, Lyon, France, 21CH, Niot, France, 22CHU, Poitiers, France, 23CHU, Bobigny, France

    Background/Purpose: Patients receiving glucocorticoids plus rituximab (RTX) show an increased risk of infection, especially invasive pneumococcal infections. Vaccine responses to influenza, Streptococcus pneumoniae and SARS-CoV-2…
  • Abstract Number: 0939 • ACR Convergence 2022

    Pilot Study: A Novel Method for Cervical Health Monitoring in African American Women with Systemic Lupus Erythematosus (SLE) Using a Self- Sampling Brush to Assess Cervical HPV Infection and Cervical Cytology

    J. Patricia Dhar1, Heather Walline2, Lamia Fathallah3, Susanna Szpunar4, Louis Saravolatz5, Gil Mor6 and Thomas Carey7, 1Ascension St. John Hospital and Wayne State University School of Medicine, Bloomfield Hills, MI, 2University of Michigan, Ann Arbor, MI, 3Ascension St.John Hospital, Detroit, MI, 4Ascension St. John Hospital, Grosse Pointe Woods, MI, 5Ascension St John Hospital and Medical Center, Wayne State University School of Medicine (affiliate), Grosse Pointe Woods, MI, 6Wayne State University and C.S. Mott Center for Human Growth and Development., Detroit, MI, 7University of Michigan School of Medicine, Ann Arbor, MI

    Background/Purpose: A health disparity exists for AA women with SLE who have increased morbidity & mortality from both cervical cancer & SLE. Current cervical cancer…
  • Abstract Number: 1932 • ACR Convergence 2022

    Efficacy of the COVID-19 Vaccine in Pediatric Systemic Lupus Erythematosus Patients

    Yi Shi1, Catherine Park2, Sangeeta Sule2 and Sun-Young Ahn2, 1Children's National Hospital, New York, NY, 2Children's National Hospital, Washington, DC

    Background/Purpose: The COVID-19 virus has caused significant morbidity and mortality, despite introduction of the COVID vaccine. Immunocompromised patients have been shown to have reduced response…
  • Abstract Number: 0945 • ACR Convergence 2022

    Contraception Documentation Patterns for Adult Females with Juvenile Idiopathic Arthritis on Teratogenic Medications in the Rheumatology Informatics System for Effectiveness (RISE) Registry

    John Bridges1, Jing Li2, Melissa Mannion3, Gabriela Schmajuk4 and Jasvinder singh3, 1University of Alabama at Birmingham/Children's of Alabama, Birmingham, AL, 2University of California, San Francisco, San Francisco, CA, 3University of Alabama at Birmingham, Birmingham, AL, 4UCSF / SFVA, San Francisco, CA

    Background/Purpose: Patients with juvenile idiopathic arthritis (JIA) have disease onset during childhood and often require anti-rheumatic medication through their reproductive years. Contraception use in reproductive-age…
  • Abstract Number: 1964 • ACR Convergence 2022

    Systematic Screening of Multimorbidities Results in an Increased Intake of Comorbidity Preventive Medications and a Decreased Hospitalization Rate

    Claire DAIEN1, Vera Georgescu2, Guillaume Decarriere3, Jenica Pastor3, Gaël Mouterde4, Cédric Lukas5, Grégoire Mercier3 and Jacques Morel6, 1University Hospital, Saint-Gély-du-Fesc, France, 2Unité de Recherche Médico-économique, CHU de Montpellier et Université de Montpellier, Montpellier, France, 3CHU Montpellier, Montpellier, France, 4Lapeyronie Hospital, Montpellier, France, 5University Hospital Centre Montpellier, University of Montpellier, Montpellier, France, 6University and CHU Montpellier, Montpellier, France

    Background/Purpose: A systematic screening of multimorbidities is performed since 2014 at the Montpellier University Hospital in patients with chronic inflammatory rheumatic diseases (IRD). The objective…
  • Abstract Number: 0064 • ACR Convergence 2022

    Utilization of Preventive Services in a Systemic Lupus Erythematosus Population-Based Cohort: A Lupus Midwest Network Study

    Baptiste Chevet1, Gabriel Figueroa Parra1, Jeffrey X. Yang1, Mehmet Hocaoglu1, Shirley-Ann Osei-Onomah1, Cassondra Hulshizer1, Tina Gunderson1, Divi CORNEC2, Cynthia Crowson3 and Ali Duarte-Garcia1, 1Mayo Clinic, Rochester, MN, 2CHRU Brest, Brest, France, 3Mayo Clinic, Eyota, MN

    Background/Purpose: Systemic lupus erythematosus (SLE) is a disease that can damage multiple organs and, along with certain treatments, increase the risk of developing cancer, cardiovascular…
  • Abstract Number: 0947 • ACR Convergence 2022

    Development of a Person-Centered Family Planning Decision Aid for Women with Rheumatic Diseases

    Mehret Birru Talabi1, Traci Kazmerski2, Raelynn O'Leary3, Ashley Deal3, Megan Clowse4, Oilvia Stransky5 and Sonya Borrero5, 1University of Pittsburgh, Pittsburgh, PA, 2Children's Hospital of Pittsburgh, Pittsburgh, 3Carnegie Mellon University School of Design, Pittsburgh, 4Duke University, Durham, NC, 5University of Pittsburgh, Pittsburgh

    Background/Purpose: Given the potential for pregnancy-associated mortality and morbidity, the question of whether and/or when to become pregnant is often a profoundly important decision for…
  • Abstract Number: 2002 • ACR Convergence 2022

    Do SMS and Email Reminders Increase the Rate of Seasonal Influenza Vaccination in RA Patients Treated with Biologics: A Nested Randomized Controlled Trial Within the ART Registry?

    Raphaèle Seror1, Gabriel Baron2, Sylvie Miconnet3, Rakiba Belkhir3, Martin Soubrier4, pascale thevenot5, andre basch6, Marie Truchetet7, Pascal Claudepierre8, Emmanuelle Dernis9, Hubert Marotte10, René-Marc Flipo11, Olivier Brocq12, Jacques Morel13, CARINE SALLIOT14, Bruno Fautrel15, Alain Saraux16, CHARLES LESKE17, Naïma Hamamouche18, Thierry schaeverbeke19, Xavier Mariette20, Adeline Ruyssen-Witrand21 and Philippe Ravaud22, 1University Hospital Paris-Saclay, Le Kremlin Bicêtre, France, 2AP-HP Hôtel Dieu Hospital, Université Paris Descartes, Paris, France, 3Rheumatology departement, Bicêtre, Paris-Saclay university, Le Kremlin Bicêtre, France, 4Gabriel-Montpied Hospital, Clermont-Ferrand, France, 5French Society of rheumatology, Paris, France, 6Infirmerie Protestante de Lyon, Caluire-et-Cuire, France, 7Bordeaux University Hospital, Bordeaux, France, 8Paris Est Creteil University, Creteil, France, 9LE MANS general hospital, LE MANS, France, 10INSERM 1059, Saint-Etienne, France, 11CHU Lille, Boulogne-Billancourt, France, 12Rheumatology- CH Princesse Grace, Monaco, Monaco, 13University and CHU Montpellier, Montpellier, France, 14CHR orleans, Orleans, France, 15Sorbonne University Paris, France and Pierre Louis Institute of Epidemiology and Public Health, Paris, France, Paris, France, 16CHU Brest, Brest, France, 17Hospital, Cholet, France, 18e-health Services Sanoïa, Gémenos, France, 19CHU de Bordeaux, Bordeaux, France, 20Paris-Saclay University, Rueil Malmaison, Ile-de-France, France, 21CHU de Toulouse, Toulouse, France, 22Université Paris Cité, Hôtel-Dieu, Paris, France

    Background/Purpose: In patients treated with biologics, vaccination against influenza is recommended. However, vaccination coverage remains very low. The use of automatic digital reminders is an…
  • Abstract Number: 0084 • ACR Convergence 2022

    Facilitators and Barriers of Vaccine Uptake in Patients with Chronic Inflammatory Rheumatic Disease: A Scoping Review

    Silke Neusser1, Anja Neumann1, Christian Speckemeier1, Pauline zur NIeden1, Sarah Schlierenkamp1, Anke Walendzik1, Ute Karbach2, Ioana Andreica3, Kristina Vaupel4, Xenofon Baraliakos5 and Uta Kiltz4, 1Essener Forschungsinstitut für Medizinmanagement, Essen, Germany, 2Institute of Medical Sociology, Health Services Research and Rehabilitation Science (IMVR), Cologne, Germany, 3Rheumazentrum Ruhrgebiet, Ruhr-Universität-Bochum, Herne, Germany, 4Rheumazentrum Ruhrgebiet, Herne, Germany, 5Rheumazentrum Ruhrgebiet Herne, Herne, Germany

    Background/Purpose: Patients with chronic inflammatory rheumatic diseases (CIRD) remain underrepresented in receiving vaccinations despite being disproportionately affected by infectious complications. The aim of our study…
  • Abstract Number: 1065 • ACR Convergence 2022

    Biosamples from VEDOSS Patients Show Pathological Signs of SSc: Opportunity for a Biololgical Diagnosis of Disease

    Rebecca Ross1, Emily Clarke1, Will Merchant1, Panji Mulipa1, Natalia Riobo-DelGaldo1 and Francesco Del Galdo2, 1University of Leeds, Leeds, United Kingdom, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health and NIHR Biomedical Research Centre, University of Leeds, Leeds, United Kingdom

    Background/Purpose: The VEDOSS study has recently indicated that more than 50% of patients affected by Raynaud’s phenomenon (RP) and specific SSc anti-nuclear antibodies (ANA) and/or…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 15
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology